21 Sept 2026, 18:18
Securities Administration—
AXEARCHER MATERIALS LIMITED
Announcement history available from 1 August 2025
Fromto
17 Sept 2026, 08:57
Meetings & Governance—
14 Sept 2026, 09:39
Company Update—
4 Sept 2026, 17:16
Securities Administration—
4 Sept 2026, 17:09
Director Interests—
4 Sept 2026, 09:46
Securities Administration—
4 Sept 2026, 09:40
Securities Administration—
4 Sept 2026, 09:20
Capital Raising—
27 Aug 2026, 09:41
Company Administration—
27 Aug 2026, 09:30
Financial ResultsMS
18 Aug 2026, 14:12
Meetings & Governance—
13 Aug 2026, 09:27
Company UpdateMS
10 Aug 2026, 09:53
Securities Administration—
10 Aug 2026, 09:50
Capital Raising—
29 July 2026, 09:32
Company UpdateMS
17 July 2026, 09:17
Meetings & Governance—
10 July 2026, 09:07
Capital Raising—
9 July 2026, 09:46
Securities Administration—
9 July 2026, 09:38
Securities Administration—
9 July 2026, 09:23
Quarterly ReportsMS
3 July 2026, 16:05
Capital Raising—
3 July 2026, 10:02
Securities Administration—
3 July 2026, 10:02
PresentationsMS
3 July 2026, 10:02
Capital RaisingMS
1 July 2026, 09:27
Company UpdateMS
1 July 2026, 09:03
Trading Halt / SuspensionMS
26 June 2026, 17:04
Securities Administration—
15 June 2026, 09:38
Company Update—
4 June 2026, 13:56
Company UpdateMS
21 May 2026, 16:41
Securities Administration—
15 May 2026, 09:20
Company UpdateMS
12 May 2026, 09:17
Company UpdateMS
4 May 2026, 09:24
Presentations—
29 Apr 2026, 09:31
Quarterly ReportsMS
22 Apr 2026, 17:37
Securities Administration—
7 Apr 2026, 10:30
Company UpdateMS
18 Mar 2026, 09:19
Company Update—
4 Mar 2026, 09:14
Financial Results—
25 Feb 2026, 09:45
Financial ResultsMS
12 Feb 2026, 09:30
Company Update—
30 Jan 2026, 09:21
Company UpdateMS
29 Jan 2026, 10:39
Presentations—
29 Jan 2026, 09:22
Quarterly ReportsMS
22 Jan 2026, 08:25
Company Administration—
9 Jan 2026, 09:26
Letters & Addresses—
1 Dec 2025, 14:32
Director Interests—
1 Dec 2025, 14:32
Director Interests—
1 Dec 2025, 14:31
Company Administration—
20 Nov 2025, 18:28
Director Interests—
20 Nov 2025, 18:26
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 21 Sept 2026, 18:18 | Notification regarding unquoted securities - AXE | Securities Administration | — | 06021 | |
| 17 Sept 2026, 08:57 | Notice Required Under ASX Listing Rule 3.13.1 | Meetings & Governance | — | 08006 | |
| 14 Sept 2026, 09:39 | Archer launches Quantum Commercial Pilot | Company Update | — | 11001 | |
| 4 Sept 2026, 17:16 | Notice under section 708A of the Corporations Act | Securities Administration | — | 06018 | |
| 4 Sept 2026, 17:09 | Change of Director's Interest Notice - GE BH | Director Interests | — | 02009 | |
| 4 Sept 2026, 09:46 | Application for quotation of securities - AXE | Securities Administration | — | 06020 | |
| 4 Sept 2026, 09:40 | Notification regarding unquoted securities - AXE | Securities Administration | — | 06021 | |
| 4 Sept 2026, 09:20 | Prospectus | Capital Raising | — | 06010, 06017 | |
| 27 Aug 2026, 09:41 | 2026 Corporate Governance Statement and Appendix 4G | Company Administration | — | 03024, 03025 | |
| 27 Aug 2026, 09:30 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 18 Aug 2026, 14:12 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 13 Aug 2026, 09:27 | Early Pre-Pilot Study Advances Potassium Biosensor | Company Update | MS | 11001 | |
| 10 Aug 2026, 09:53 | Application for quotation of securities - AXE | Securities Administration | — | 06020 | |
| 10 Aug 2026, 09:50 | Results of Share Purchase Plan | Capital Raising | — | 06017 | |
| 29 July 2026, 09:32 | Biochip Advances Towards Clinical-Ready Device Development | Company Update | MS | 11001 | |
| 17 July 2026, 09:17 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 10 July 2026, 09:07 | Dispatch of Share Purchase Plan Offer Booklet | Capital Raising | — | 06010, 06017 | |
| 9 July 2026, 09:46 | Completion of A$6.86m Tranche 1 Placement, s708A Notice | Securities Administration | — | 06018 | |
| 9 July 2026, 09:38 | Application for quotation of securities - AXE | Securities Administration | — | 06020 | |
| 9 July 2026, 09:23 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 3 July 2026, 16:05 | AXE to host webinar - IonQ Strategic Partnership and SPP | Capital Raising | — | 06017, 14014 | |
| 3 July 2026, 10:02 | Proposed issue of securities - AXE | Securities Administration | — | 06013 | |
| 3 July 2026, 10:02 | Presentation - Bringing Quantum Computing to Australia | Presentations | MS | 03026 | |
| 3 July 2026, 10:02 | Archer Completes $7m Placement and Launches SPP Offer | Capital Raising | MS | 06003, 06017, 09014 | |
| 1 July 2026, 09:27 | Archer enters strategic agreement with quantum leader, IonQ | Company Update | MS | 11001 | |
| 1 July 2026, 09:03 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 26 June 2026, 17:04 | Notification of cessation of securities - AXE | Securities Administration | — | 06027 | |
| 15 June 2026, 09:38 | AXE advances quantum strategy amid growing global momentum | Company Update | — | 11001 | |
| 4 June 2026, 13:56 | Archer QML Project achieves key milestones | Company Update | MS | 11001 | |
| 21 May 2026, 16:41 | Notification of cessation of securities - AXE | Securities Administration | — | 06027 | |
| 15 May 2026, 09:20 | Biosensor beta prototype and manufacturing pathway advanced | Company Update | MS | 11001 | |
| 12 May 2026, 09:17 | Archer strengthens pathway to quantum device manufacturing | Company Update | MS | 11001 | |
| 4 May 2026, 09:24 | Archer to host quarterly update investor webinar | Presentations | — | 14014 | |
| 29 Apr 2026, 09:31 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 22 Apr 2026, 17:37 | Notification of cessation of securities - AXE | Securities Administration | — | 06027 | |
| 7 Apr 2026, 10:30 | Biochip advances toward beta prototype & clinical validation | Company Update | MS | 11001 | |
| 18 Mar 2026, 09:19 | Archer to commence QML simulations and benchmarking | Company Update | — | 11001 | |
| 4 Mar 2026, 09:14 | 1H FY26 Update - Presentation | Financial Results | — | 03004, 03026, 14014 | |
| 25 Feb 2026, 09:45 | Appendix 4D and Half Year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019, 14014 | |
| 12 Feb 2026, 09:30 | Quantum program advances with ecosystem-led execution | Company Update | — | 11001 | |
| 30 Jan 2026, 09:21 | Archer develops early Biochip prototype | Company Update | MS | 11001 | |
| 29 Jan 2026, 10:39 | Investor Webinar - Presentation | Presentations | — | 03026, 14014, 19007 | |
| 29 Jan 2026, 09:22 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19002, 19007 | |
| 22 Jan 2026, 08:25 | Archer to host quarterly update investor webinar | Company Administration | — | 12008 | |
| 9 Jan 2026, 09:26 | Letter to Shareholders | Letters & Addresses | — | 16002 | |
| 1 Dec 2025, 14:32 | Final Director's Interest Notice - KW | Director Interests | — | 02010 | |
| 1 Dec 2025, 14:32 | Initial Director's Interest Notice - AJ | Director Interests | — | 02008 | |
| 1 Dec 2025, 14:31 | Archer Board Changes | Company Administration | — | 12001 | |
| 20 Nov 2025, 18:28 | Change of Director's Interest Notice - GE | Director Interests | — | 02009 | |
| 20 Nov 2025, 18:26 | Notification regarding unquoted securities - AXE | Securities Administration | — | 06021 |
1–50 of 70
1 / 2